Correlation Between Protara Therapeutics and Poniard Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Poniard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Poniard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protara Therapeutics and Poniard Pharmaceuticals, you can compare the effects of market volatilities on Protara Therapeutics and Poniard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Poniard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Poniard Pharmaceuticals.

Diversification Opportunities for Protara Therapeutics and Poniard Pharmaceuticals

0.0

Correlation Coefficient

Protara Therapeutics  Poniard Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Protara and Poniard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Poniard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Poniard Pharmaceuticals and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Poniard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Poniard Pharmaceuticals has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Poniard Pharmaceuticals go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Poniard Pharmaceuticals

If you would invest (100.00) in Poniard Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Poniard Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Protara Therapeutics  vs.  Poniard Pharmaceuticals

Protara Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Protara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Poniard Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Poniard Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Poniard Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Protara Therapeutics and Poniard Pharmaceuticals

The main advantage of trading using opposite Protara Therapeutics and Poniard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Poniard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Poniard Pharmaceuticals will offset losses from the drop in Poniard Pharmaceuticals' long position.

The idea behind Protara Therapeutics and Poniard Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..